More importantly, the activation of RNase L could suppress tumor initiation and the enrichment of cancer stem cells, highlighting the RNase L as a critical initiator of apoptosis in lung cancer cells and suggesting promising therapeutics targeting RNase L as a novel treatment for lung cancer. This evidence concerns the gene RNASEL and neoplasm.